ADIAL PHARMACEUTICALS, INC. — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Adial Pharmaceuticals filed a current report on 2026-10-16 reporting for the period ending 2026-10-15. The filing contains Item 8.01 (Other Events) but the specific content of that event is not disclosed in the provided document index. No counterparties, dollar amounts, share counts, or material transactions are specified in the available text.
Why this rating
Filing is administrative/procedural with no disclosed material event details. Cannot assess business impact without content.
Extracted items
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.